In short. Acne in different skin tones behaves the same way at the follicle but leaves different marks behind. In darker skin, active melanin cells make post-inflammatory hyperpigmentation and raised or keloid scarring more likely after any inflammation, so the plan treats pigment risk alongside the acne rather than after it.
Key points
- Melanin cells in darker skin respond more strongly to inflammation, so marks are more likely.
- Post-inflammatory hyperpigmentation is brown pigment; post-inflammatory erythema is persistent redness or purple-brown discolouration.
- Raised and keloid scars are more common, and redness is harder to see against deeper tones.
- Treatment goals are unchanged, but settings are conservative, test areas are used, and sessions are spaced.
- Sun protection is part of treatment because ultraviolet light darkens marks and slows fading.
What changes in skin of colour?
Acne is universal, but its aftermath is not. In skin of colour, including East Asian, South Asian, African, Middle Eastern and Mediterranean skin, inflammation is far more likely to leave a mark behind, and for many people the marks, not the acne, become the main concern. Melanin-producing cells in darker skin are more active and respond more vigorously to inflammation, so almost any insult — a pimple, a scratch, a squeeze, an aggressive facial — can leave pigment behind. Darker skin also scars differently: raised and keloid scars are more common, and a scar that would be a fine line in lighter skin may thicken and spread. At the same time, some features of acne, redness in particular, are harder to see against a deeper skin tone, so inflammation can be underestimated by both patients and clinicians. Good lighting and a dermatoscope matter more here, not less.
Two marks that need different names
Two changes matter. Post-inflammatory hyperpigmentation is brown pigment deposited in healing skin. Post-inflammatory erythema is redness, or a purple-brown discolouration, that persists after the lesion has settled. Both can last far longer than the pimple that caused them, and both are often described together as "marks"; they are not the same thing, and both are reasons to treat inflammation early rather than wait for the acne to clear.
What this means for treatment
The goals are the same, but the risk calculation differs. Treatments that reliably help lighter skin can cause unwanted pigmentation or lightening in darker skin if they are too aggressive, so settings are chosen conservatively, test areas are used where appropriate, and procedures are spaced rather than stacked. Inflammation is treated earlier and more decisively, because every inflamed lesion is a potential mark. Sun protection becomes a core part of treatment rather than general health advice: ultraviolet light darkens marks and slows their fading.
| What differs | In darker skin | What changes in the plan |
|---|---|---|
| Melanin response | Cells are more active; almost any insult can leave pigment | Treat inflammation early and decisively |
| Mark type | Hyperpigmentation is brown pigment; erythema is redness or purple-brown discolouration | Use pigment-directed topicals such as azelaic acid or a retinoid |
| Scarring | Raised and keloid scars are more common; a scar may thicken and spread | Use a separate protocol: silicone, intralesional injection or laser, not simple excision |
| Visibility | Redness is harder to see against a deeper tone | Use good lighting and a dermatoscope; do not underestimate inflammation |
| Procedure tolerance | Aggressive treatment can cause pigmentation or lightening | Start conservatively, use test areas where appropriate, and space sessions |
| Sun exposure | Ultraviolet light darkens marks and slows fading | Make sun protection part of treatment |
| Timeline | Marks can last far longer than the lesion; routine work takes months, not weeks | Judge progress over months; aim for fewer new marks, faster fading and a more even tone |
Practical differences in the plan
Expect marks to be treated alongside the acne rather than after it. Choose pigment-directed topicals such as azelaic acid or a retinoid as part of the routine. Where procedures are used, start at conservative settings and build gradually across sessions. Treat raised or keloid-prone scars with their own protocol, which may include silicone, intralesional injection or laser rather than simple excision.
How do you break the cycle?
Because marks follow inflammation, the fastest way to reduce marks is to reduce inflammation and keep hands away from the skin. Picking, squeezing and harsh scrubbing all increase the chance of a permanent mark. A calm, consistent, sun-protected routine does more for an even complexion than any single brightening product, and it works over months rather than weeks.
What can treatment realistically achieve?
Most marks fade substantially with time and protection. Some leave a faint trace that persists, and treatment can lighten it further but not always remove it completely. That is worth knowing before treatment begins, because it changes what success looks like: fewer new marks, faster fading and a more even tone rather than flawless skin.
When should the plan be reviewed?
- Marks are darker or more extensive than the acne itself — pigment needs its own plan.
- A scar is thickening, itching or growing beyond its original boundary.
- Previous treatment caused lightening or darkening of the treated skin — the settings and agents need review.
Sources
- American Academy of Dermatology — acne and pigmentation information
- NICE Clinical Knowledge Summaries — acne vulgaris, including referral criteria
- British Association of Dermatologists — acne patient information
Internal links
Frequently asked questions
Why does acne leave more marks in darker skin?
Melanin-producing cells in darker skin are more active and respond more vigorously to inflammation, so almost any insult, including a pimple, a scratch or a squeeze, can leave pigment behind. Marks can last far longer than the lesion that caused them and often become the main concern.
Does acne treatment differ in skin of colour?
The goals are the same but the risk calculation differs. Treatments that reliably help lighter skin can cause unwanted pigmentation or lightening in darker skin if they are too aggressive, so settings are conservative, test areas are used where appropriate, and procedures are spaced rather than stacked.
Will the marks from acne ever go away completely?
Most marks fade substantially with time and protection. Some leave a faint trace that persists, and treatment can lighten it further but not always remove it completely. That changes what success looks like: fewer new marks, faster fading and a more even tone rather than flawless skin.
Risks & Limitations
- Most chronic skin disease is managed rather than cured, and relapse is expected.
- Treatments typically need 8–12 weeks before response can be judged fairly.
- Topical treatment can cause irritation, dryness, peeling and photosensitivity.
- Systemic therapy may require blood monitoring and carries organ, metabolic and pregnancy risks.
- Isotretinoin in particular requires strict monitoring and pregnancy prevention.
- Pigment change is often slow and may be incomplete.
- No treatment works for everyone, and response cannot be predicted with certainty.
When to Seek Care
- A mole or lesion that changes in size, shape or colour, or starts to bleed, itch or crust.
- Fever with a widespread rash, blistering, or rash involving the eyes, mouth or genitals — seek emergency care.
- Rapidly spreading redness, swelling or pain in the skin.
- Facial swelling or difficulty breathing — possible severe reaction; seek emergency care immediately.
- New or worsening symptoms while taking a monitored medication.
References & Further Reading
- American Academy of Dermatology (AAD) — public and clinical guidance
- World Health Organization (WHO) — skin and infectious disease resources
- Chinese Medical Association, Dermatology Branch — clinical guidance
- Cochrane Library — systematic reviews in dermatology
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.